Get the Stockscreener App
1.03
3.96%
0.0392
After Hours:
.98
-0.05
-4.85%
Iridex Corp stock is traded at $1.03, with a volume of 142.14K.
It is up +3.96% in the last 24 hours and down -25.36% over the past month.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$0.9908
Open:
$1
24h Volume:
142.14K
Relative Volume:
2.04
Market Cap:
$16.48M
Revenue:
$48.43M
Net Income/Loss:
$-11.04M
P/E Ratio:
-1.5373
EPS:
-0.67
Net Cash Flow:
$-7.00M
1W Performance:
+14.50%
1M Performance:
-25.36%
6M Performance:
-39.77%
1Y Performance:
-65.89%
1-Day Range:
$1.00
$1.10
1-Week Range:
$0.8781
$1.10
52-Week Range:
$0.782
$3.65
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.03 | 16.48M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Call Transcript - MSN
Iridex: Q4 Earnings Snapshot - MySA
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... - Yahoo Finance UK
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic I - GuruFocus
Iridex Corporation Reports Improved Financial Performance - TipRanks
IRIDEX earnings matched, revenue fell short of estimates - Investing.com
Earnings call transcript: IRIDEX Q4 2024 sees aftermarket stock surge - Investing.com
IRIDEX Corp Q4 2024 Earnings: EPS Meets Estimate at -$0.05, Reve - GuruFocus
IRIDEX Earnings Results: $IRIX Reports Quarterly Earnings - Nasdaq
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance
Earnings Preview For Iridex - Benzinga
IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Iridex secures $10 million investment for growth initiatives By Investing.com - Investing.com
Iridex Corporation Closes $10 Million Strategic Investment with Novel Inspiration International Co., Ltd. - Nasdaq
Iridex Announces Strategic Investment in the Company - Yahoo Finance
Iridex Stock: Volatility Persists Amid Stable Fundamentals - Sharewise
Iridex addresses recent stock volatility - Investing.com
Iridex Comments on Recent Stock Price Volatility - Yahoo Finance
Iridex Corporation to Announce Q4 and Full Year 2024 Financial Results on March 27, 2025 - Nasdaq
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewswire Inc.
Medical Laser Leader Iridex Sets Critical Year-End Earnings Report Date - StockTitan
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Iridex reports steady Q4 sales, eyes profitability in 2025 - Investing.com
Iridex Reports Mixed Q4 Results: Revenue Up, Achieves Positive EBITDA Amid Strategic Review - StockTitan
IRIDEX (NASDAQ:IRIX) Stock Passes Below 200 Day Moving Average – Time to Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - Yahoo Finance
Iridex Announces Milestone Five-Year Study Confirms the - GlobeNewswire
Medical Lasers Market Focused Insights 2024-2029: Mergers, - GlobeNewswire
Veterinary Eye Care Market to Grow by USD 1.05 Billion (2024-2028), Report on AI-Powered Market Evolution and Rising Pet OwnershipTechnavio - The Malaysian Reserve
United States Retinal Surgery Devices Market - GlobeNewswire
IRIX Stock Surges Over 6% Amidst Medical Device Sector Decline - GuruFocus.com
Advancing Healthcare Tech: Medical Lasers Market Report 2024 - WhaTech
IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript - MSN
Iridex's Glaucoma Treatment Exempt from New Medicare Reimbursement Limits | IRIX Stock News - StockTitan
IRIDEX Corp adjusts executive compensation, reshuffles board By Investing.com - Investing.com Australia
IRIDEX Corp adjusts executive compensation, reshuffles board - Investing.com India
3 US Penny Stocks With Market Caps Under $50M To Watch - Yahoo Finance
IRIDEX earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic M - GuruFocus.com
IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... - Yahoo Finance
Iridex: Q3 Earnings Snapshot - The Washington Post
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):